Pharmacotherapy of the Ophthalmic Patient

Clinical Ocular Pharmacology

Volumn , Issue , 2008, Pages 3-15

  Coulter, Rachel A ^a   Bartlett, Jimmy D ^b,c   Fiscella, Richard G ^d  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882564220     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7506-7576-5.50006-9     Document Type: Chapter

References (34)

1. Abelson MB, Paradis A, Grant KK How to prescribe for the smallest sufferers. Rev Ophthalmol 1999, 6(2):101-103.
2. Akman A, Aydin P. Comparison of mydriatic efficacy of spray instillation and drop instillation of tropicamide 1%. Eye 199; 13: 653-655.
3. Bartlett JD Medications and contact lens wear. Anterior segment complications of contact lens wear 2000, Butterworth-Heinemann, Boston. ed. 2. J. Silbert (Ed.).
4. Bartlett JD Ophthalmic toxicity by systemic drugs. Ophthalmic toxicology 1999, Taylor & Francis, Philadelphia. ed. 2. G.C.Y. Chiou (Ed.).
5. Ophthalmic drug facts 2006, Wolters Kluwer Health, St. Louis, MO. J.D. Bartlett, E.S. Bennett, R.G. Fiscella (Eds.).
6. Congdon N, O'Colmain B, Klaver CC Eye Diseases Prevalence Research Group: causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004, 122:477-485.
7. Coulter RA Pediatric use of topical ophthalmic drugs. Optometry 2004, 75:419-429.
8. Drummond SR, Drummond RS, Dutton GN Visual acuity and the ability of the visually impaired to read medication instructions. Br J Ophthalmol 2004, 88:1541-1542.
9. Fiscella R When generic drugs are not the right Rx. Rev Optom 2002, 139:1-5.
10. Fiscella R, Bloch D, Labib S, Jensen M Compounding in ophthalmology: know the risks. Rev Ophthalmol 2005, October:55-61.
11. Fiscella R, Wilensky J, et al. Medical therapy cost considerations for glaucoma. Am J Ophthalmol 2003, 136:18-25.
12. Fiscella R, Wilensky JT, Chiang TH, Walt J Efficiency of instillation methods for prostaglandin medications. J Ocul Pharmacol Ther 2006, 22:477-482.
13. Fraunfelder FT, Fraunfelder FW Drug-induced ocular side effects 2001, Butterworth-Heinemann, Boston. ed. 5.
14. Jaanus SD Pharmacologic aspects of aging. Vision and aging 1993, ButterworthHeinemann, Boston. ed. 2. A. Rosenbloom, M. Morgan (Eds.).
15. Jampel HD, Schwartz GF, Robin AL, et al. Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 2003, 121:540-546.
16. Johnson SM, Martinez M, Freedman S Management of glaucoma in pregnancy and lactation. Surv Ophthalmol 2001, 45:449-454.
17. Kaplan S The importance of the therapeutic alliance. J Am Optom Assoc 1998, 69:637-642.
18. Khurana RN, Lee PP, Challa P Readability of ocular medication inserts. J Glaucoma 2003, 12:50-53.
19. Mauger TF, Craig EL Havener's ocular pharmacology 1994, Mosby, St. Louis, MO. ed. 6.
20. McPhillips R Can the elderly afford eye care? Can we afford eye care for the elderly?. Ophthalmology 1987, 94:1199-1204.
21. Metry DW, Hebert AA Topical therapies and medications in the pediatric patient. Pediatr Clin North Am 2000, 47:867-876.
22. Nordenberg T Pediatric drug studies. FDA Consum 1999, 33:23-28.
23. Platt R, Reardon G, Mozaffari E Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size. Am J Ophthalmol 2004, 137:S17-S23.
24. Repka MX, et al. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005, 123:149-157.
25. Ritch R, et al. An improved technique of eye drop self-administration for patients with limited vision. Am J Ophthalmol 2003, 135:530-533.
26. Solomon A, et al. Inadvertent conjunctival trauma related to contact with drug container tips: a masquerade syndrome. Ophthalmology 2003, 110:796-800.
27. Stewart WC, Garrison PM β-blocker induced complications in the patient with glaucoma. Arch Intern Med 1998, 158:221-226.
28. Taylor SA, Galbraith SM, Mills RP Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther 2002, 18:401-409.
29. Urtti A, Salminen L Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol 1993, 37:435-456.
30. Watson PD, Getschman S, Koren G Principles of drug prescribing in infants and children, a practical guide. Drugs 1993, 46:281-288.
31. Wilensky J, Fiscella R, Carlson AM, et al. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data. Am J Ophthalmol 2006, 141:S28-S33.
32. Willcox SM, Himmelstein DU, Woolhandler S Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994, 272:292-296.
33. Yuen J, Fiscella R, Gaynes B Ophthalmic agents and managed care. JMCP 2002, 8:217-223.
34. Zimmerman TJ, et al. Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion. Am J Ophthalmol 1992, 114:1-7.